Glenmark Pharmaceuticals

Glenmark Life Sciences shares listed at a weak premium at the moment. (Picture: REUTERS) Glenmark Life Sciences shares made a weak itemizing on the inventory exchanges at the moment, marred by the muted market momentum. Glenmark Life Sciences’ shares started buying and selling at Rs 751 per share, up 4.32% from the IPO worth of
0 Comments
According to the shareholding pattern of Glenmark Pharmaceuticals Ltd, the promoter and promoter group collectively hold 13.15 crore shares. Glenmark Life Sciences Ltd, a subsidiary of Glenmark Pharmaceuticals Ltd, filed a Draft Red Herring Prospectus (DRHP) with the capital markets regulator SEBI for its initial public offering (IPO). The public issue will comprise a fresh
0 Comments